IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)

Objective: To study the frequency of In-Stent Restenosis and its treatment in patients undergoing Percutaneous Coronary Intervention for coronary artery disease. Study Design: Descriptive cross sectional study. Place and Duration of Study: Department of Cardiology, Armed Forces Institute of Ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Waseem Raja, Naseer Ahmed Samore, Mohsin Saif, Javeria Kamran, Sidra Waheed, Naeem Tariq, Farhan Tuyyab, Abdul Hameed Siddiqui
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2020
Materias:	coronary artery disease percutaneous coronary intervention restenosis Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/933dc641491e4d1db1a71a18e736ce5c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:933dc641491e4d1db1a71a18e736ce5c
record_format	dspace
spelling	oai:doaj.org-article:933dc641491e4d1db1a71a18e736ce5c2021-12-02T17:18:47ZIN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)doi.org/10.51253/pafmj.v70iSuppl-4.60450030-96482411-8842https://doaj.org/article/933dc641491e4d1db1a71a18e736ce5c2020-12-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/6045https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To study the frequency of In-Stent Restenosis and its treatment in patients undergoing Percutaneous Coronary Intervention for coronary artery disease. Study Design: Descriptive cross sectional study. Place and Duration of Study: Department of Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart disease (AFIC/NIHD) Rawalpindi, from Jul 2017 to Jul 2019. Methodology: All the patients who underwent Percutaneous Coronary Intervention for Coronary Artery Disease at our institute were considered for this study. A consecutive sampling method was used and inclusion/exclusion criteria was applied. Following data was obtained; 1) Demographic information and clinical risk factors like history of hypertension, hyperlipidemia, diabetes mellitus, smoking, coronary artery disease characteristics (number of diseased arteries, bifurcation lesions, calcification, chronic total occlusions-CTO and tortuosity) 3), Stent factors (under expansion, fracture, longitudinal miss, stent gap). Data recording, storage, assessment and analysis was done by using SPSS software version 21. Results: Among 1332 cases, 50 had In-Stent Restenosis with overall prevalence of 3.75%. Mean age of the patients with In-Stent Restenosis was 58.76 (± 9.97), with 45 (90%) male and 5 (10%) female. Diabetes Mellitus was the commonest risk factor (22.9%) followed by Hypertension (18%). Sixty four percent of the patients (n=32) had Single Vessel Coronary Artery Disease, 14 (28%) had Double Vessel Coronary Artery Disease and 4 (8%) had Tripple Vessel Coronary Artery Disease. Left Anterior Descending was the commonest coronary artery that developed In-Stent Restenosis, followed by Right Coronary Artery and Left Circumflex respectively. Previously deployed stents which developed In-Stent Restenosis showed longitudinal geographical miss in 16%, stent under expansion in 6% and stent gap in 4%. There was statistically significant association (p-value=0.02) between stent length and frequency of In-Stent Restenosis and it was commonest in stents longer than 30 mm. Eighty six percent (n=43) of In-Stent Restenosis cases in our study group was treated with Drug Eluting Stent followed by Drug Eluting Balloon in 32% and Plain Old Balloon Angioplasty in 22%. Conclusion: History of diabetes mellitus and greater stent length were major risk factors in developing In-Stent Restenosis in our study. DES was the commonest treatment modality used.Waseem RajaNaseer Ahmed SamoreMohsin SaifJaveria KamranSidra WaheedNaeem TariqFarhan TuyyabAbdul Hameed SiddiquiArmy Medical College Rawalpindiarticlecoronary artery diseasepercutaneous coronary interventionrestenosisMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 4, Pp 865-870 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	coronary artery disease percutaneous coronary intervention restenosis Medicine R Medicine (General) R5-920
spellingShingle	coronary artery disease percutaneous coronary intervention restenosis Medicine R Medicine (General) R5-920 Waseem Raja Naseer Ahmed Samore Mohsin Saif Javeria Kamran Sidra Waheed Naeem Tariq Farhan Tuyyab Abdul Hameed Siddiqui IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
description	Objective: To study the frequency of In-Stent Restenosis and its treatment in patients undergoing Percutaneous Coronary Intervention for coronary artery disease. Study Design: Descriptive cross sectional study. Place and Duration of Study: Department of Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart disease (AFIC/NIHD) Rawalpindi, from Jul 2017 to Jul 2019. Methodology: All the patients who underwent Percutaneous Coronary Intervention for Coronary Artery Disease at our institute were considered for this study. A consecutive sampling method was used and inclusion/exclusion criteria was applied. Following data was obtained; 1) Demographic information and clinical risk factors like history of hypertension, hyperlipidemia, diabetes mellitus, smoking, coronary artery disease characteristics (number of diseased arteries, bifurcation lesions, calcification, chronic total occlusions-CTO and tortuosity) 3), Stent factors (under expansion, fracture, longitudinal miss, stent gap). Data recording, storage, assessment and analysis was done by using SPSS software version 21. Results: Among 1332 cases, 50 had In-Stent Restenosis with overall prevalence of 3.75%. Mean age of the patients with In-Stent Restenosis was 58.76 (± 9.97), with 45 (90%) male and 5 (10%) female. Diabetes Mellitus was the commonest risk factor (22.9%) followed by Hypertension (18%). Sixty four percent of the patients (n=32) had Single Vessel Coronary Artery Disease, 14 (28%) had Double Vessel Coronary Artery Disease and 4 (8%) had Tripple Vessel Coronary Artery Disease. Left Anterior Descending was the commonest coronary artery that developed In-Stent Restenosis, followed by Right Coronary Artery and Left Circumflex respectively. Previously deployed stents which developed In-Stent Restenosis showed longitudinal geographical miss in 16%, stent under expansion in 6% and stent gap in 4%. There was statistically significant association (p-value=0.02) between stent length and frequency of In-Stent Restenosis and it was commonest in stents longer than 30 mm. Eighty six percent (n=43) of In-Stent Restenosis cases in our study group was treated with Drug Eluting Stent followed by Drug Eluting Balloon in 32% and Plain Old Balloon Angioplasty in 22%. Conclusion: History of diabetes mellitus and greater stent length were major risk factors in developing In-Stent Restenosis in our study. DES was the commonest treatment modality used.
format	article
author	Waseem Raja Naseer Ahmed Samore Mohsin Saif Javeria Kamran Sidra Waheed Naeem Tariq Farhan Tuyyab Abdul Hameed Siddiqui
author_facet	Waseem Raja Naseer Ahmed Samore Mohsin Saif Javeria Kamran Sidra Waheed Naeem Tariq Farhan Tuyyab Abdul Hameed Siddiqui
author_sort	Waseem Raja
title	IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
title_short	IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
title_full	IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
title_fullStr	IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
title_full_unstemmed	IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
title_sort	in stent restenosis (isr) in patients undergoing percutaneous coronary intervention (pci) for coronary artery disease (cad)
publisher	Army Medical College Rawalpindi
publishDate	2020
url	https://doaj.org/article/933dc641491e4d1db1a71a18e736ce5c
work_keys_str_mv	AT waseemraja instentrestenosisisrinpatientsundergoingpercutaneouscoronaryinterventionpciforcoronaryarterydiseasecad AT naseerahmedsamore instentrestenosisisrinpatientsundergoingpercutaneouscoronaryinterventionpciforcoronaryarterydiseasecad AT mohsinsaif instentrestenosisisrinpatientsundergoingpercutaneouscoronaryinterventionpciforcoronaryarterydiseasecad AT javeriakamran instentrestenosisisrinpatientsundergoingpercutaneouscoronaryinterventionpciforcoronaryarterydiseasecad AT sidrawaheed instentrestenosisisrinpatientsundergoingpercutaneouscoronaryinterventionpciforcoronaryarterydiseasecad AT naeemtariq instentrestenosisisrinpatientsundergoingpercutaneouscoronaryinterventionpciforcoronaryarterydiseasecad AT farhantuyyab instentrestenosisisrinpatientsundergoingpercutaneouscoronaryinterventionpciforcoronaryarterydiseasecad AT abdulhameedsiddiqui instentrestenosisisrinpatientsundergoingpercutaneouscoronaryinterventionpciforcoronaryarterydiseasecad
_version_	1718381098622255104

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)

Ejemplares similares